(NP (NP (NP Glucocorticoid/NN receptors/NNS) (PP in/IN (NP normal/JJ leukocytes/NNS)) :/:) (NP (NP effects/NNS) (PP of/IN (NP-COOD (NP age/NN) ,/, (NP gender/NN) ,/, (NP season/NN) ,/, and/CC (NP plasma/NN cortisol/NN concentrations/NNS))) ./.))
(S (NP-SBJ We/PRP) (VP measured/VBD (NP (NP (NP glucocorticoid/NN receptors/NNS) (PRN -LRB-/-LRB- (NP GR/NN) -RRB-/-RRB-)) (PP in/IN (NP (NP (NP mononuclear/JJ leukocytes/NNS) (PRN -LRB-/-LRB- (NP MNL/NN) -RRB-/-RRB-)) (VP isolated/VBN (NP */-NONE-) (PP from/IN (NP (NP peripheral/JJ blood/NN) (PP of/IN (NP (NP 145/CD (ADJP apparently/RB healthy/JJ) volunteers/NNS) (PRN -LRB-/-LRB- (NP-COOD (NP 86/CD men/NNS) and/CC (NP 59/CD women/NNS)) -RRB-/-RRB-)))))))))) ./.)
(S (S (NP-SBJ-7 (NP An/DT age-related/JJ decrease/NN) (PP in/IN (NP (NP the/DT number/NN) (PP of/IN (NP GR/NN))))) (VP was/VBD (VP suggested/VBN (NP *-7/-NONE-) (PP between/IN (NP-COOD (NP (NP subjects/NNS) (ADJP (ADJP younger/JJR) (PP than/IN (NP 20/CD years/NNS)))) and/CC (NP elderly/JJ subjects/NNS))))) ;/:) (S (NP-SBJ there/EX) (VP was/VBD (NP-PRD (NP no/DT apparent/JJ seasonal/JJ variation/NN) (PP in/IN (NP GR/NN)))) ./.))
(S (NP-SBJ (NP Gender/NN difference/NN) (PP in/IN (NP (NP the/DT number/NN) (PP of/IN (NP GR/NN))))) (VP was/VBD not/RB (ADJP-PRD significant/JJ) ,/, (SBAR although/IN (S (NP-SBJ women/NNS) (VP showed/VBD (NP (ADJP slightly/RB fewer/JJR) GR/NN))))) ./.)
(S (NP-SBJ-8 (NP Eight/CD patients/NNS) (PP with/IN (NP dermatomyositis\/polymyositis/NN))) (VP were/VBD (VP examined/VBN (NP *-8/-NONE-) (S (NP-SBJ */-NONE-) (VP to/TO (VP determine/VB (SBAR whether/IN (S (NP-SBJ-9 (NP the/DT number/NN) (PP of/IN (NP (NP GR/NN) (PP in/IN (NP MNL/NN))))) (VP could/MD (VP be/VB (VP down-regulated/VBN (NP *-9/-NONE-) (PP by/IN (NP-LGS their/PRP$ cognate/JJ ligands/NNS)))))))))))) ./.)
(S (NP-SBJ-10 (NP The/DT number/NN) (PP of/IN (NP (NP GR/NN) (PP in/IN (NP (NP MNL/NN) (PP from/IN (NP these/DT patients/NNS))))))) (VP was/VBD (ADVP significantly/RB) (VP decreased/VBN (NP *-10/-NONE-) (PP-TMP (NP one/CD month/NN) after/IN (NP (NP the/DT initiation/NN) (PP of/IN (NP prednisolone/NN therapy/NN)))))) ./.)
(S (ADVP However/RB) ,/, (PP in/IN (NP normal/JJ subjects/NNS)) ,/, (NP-SBJ (NP the/DT GR/NN) (PP in/IN (NP MNL/NN))) (VP did/VBD not/RB (VP demonstrate/VB (NP circadian/JJ variation/NN) ,/, (PP in/IN contrast/NN to/TO (NP (NP concentrations/NNS) (PP of/IN (NP plasma/NN cortisol/NN)))))) ./.)
